您的位置: 首页 > 国外期刊 > Advances in Alzheimers Disease
Advances in Alzheimers Disease

《Advances in Alzheimers Disease》

ISSN Print:2169-2459ISSN Online:2169-2467
Indexing:
Web of Science (Clarivate Analytics)
There are 117 citations for articles published in the journal AAD as of June 2018, which increase by 44% compared to 81 citations as of June 2017.
Please click the following link to see screenshot.

Google Scholar
There are 342 citations for articles published in the journal AAD as of December 2018 based on the statistics from Google Scholar.
The 2-year Google-based Journal Impact Factor (2-GJIF) is 1.10.


PubMed and PubMed Central
Some papers from AAD have been indexed by PubMed and PubMed Central. Clicking the following link for more details:
PubMed: http://www.ncbi.nlm.nih.gov/pubmed/?term=2332-1768
PubMed Central: http://www.ncbi.nlm.nih.gov/pubmed/?term=2332-1768

AAD has been indexed by several world class databases. For more information, please access the following links:

Academic keys
Base Search
Blyun
CALIS
Chemical Abstracts Service(CAS)
CNKI SCHOLAR
COPAC
CrossRef
EBSCO A-to-Z
Elektronische Zeitschriftenbibliothek(EZB)
eReading(CNPIEC)
Geneva Foundation for Medical Education and Research(GFMER)
Gold Rush
Harvard Library E-Journals
Infotrieve
i-Scholar
JournalSeek
JournalTOCs
National Science and Technology Library(NSTL)
OneSearch
Open Access Library
Open J-Gate
Open Science Directory
Polish Scholarly Bibliography (PBN)
PUBDB DESY Publication Database
PubFacts
Research Bible
SciLit
SHERPA/RoMEO
Standard Periodical Directory (Mediafinder)
Stanford University Libraries
Système Universitaire de Documentation (Sudoc)
WanFang
Worldcat
Zeitschriftendatenbank (ZDB)
Aims & Scope:
Advances in Alzheimer's Disease (AAD) is an openly accessible journal published quarterly. The goal of this journal is to provide a platform for scientists and academicians all over the world to promote, share, and discuss various new issues and developments in different areas of Alzheimer's Disease.


All manuscripts must be prepared in English and are subject to a rigorous peer-review process. Generally, accepted papers will appear online within 3 weeks followed by printed hard copy. The areas of Advances Alzheimer's Disease (AAD) include but are not limited to the following fields:

· Alzheimer's Disease and Down Syndrome
· Animal Models of Alzheimer's Disease
· Behavior and Treatment
· Brain Disorder
· Caregiving and Dementia
· Cell cycle and AD
· Dementia during Aging and in Alzheimer's Disease
· Epidemiology of Alzheimer's Disease
· Etiology of Alzheimer's Disease
· Genetics of Alzheimer's Disease
· Inflammation in Alzheimer's Disease
· Neural Circuit Dysfunction in Alzheimer’s Disease
· Neurodegeneration
· Oxidative Stress and AD
· Pathogenesis of Alzheimer's Disease
· Patient Care and Prevention of Alzheimer’s Disease
· Progress in Alzheimer’s Disease Diagnosis
· Protein Misfolding
· Psychosocial Intervention
· Therapeutic Development
· Understanding of Alzheimer’s Disease Pathogenesis

We are also interested in:
1) Short reports—2-5 page papers where an author can present an idea with theoretical background, but has not yet completed the research needed for a complete paper or an author presents preliminary data;
2) Short communications—2-5 page papers;
3) Technical notes—2-5 page papers;
4) Letters to the Editor;
5) Reviews or book reviews—comments and critiques (the number of pages is not restricted);
6) Advertisement.